Objective:The open-label,phase II RATIONALE-209 study evaluated tislelizumab(anti-programmed cell death protein 1 antibody)as a tissue-agnostic monotherapy for microsatellite instability-high(MSI-H)/mismatch repair-de...Objective:The open-label,phase II RATIONALE-209 study evaluated tislelizumab(anti-programmed cell death protein 1 antibody)as a tissue-agnostic monotherapy for microsatellite instability-high(MSI-H)/mismatch repair-deficient(dMMR)tumors.Methods:Adults with previously treated,locally advanced unresectable or metastatic MSI-H/dMMR solid tumors were enrolled.Patients received tislelizumab 200 mg intravenously every 3 weeks.Objective response rate(ORR;primary endpoint),duration of response(DoR),and progression-free survival(PFS)were assessed by independent review committee(Response Evaluation Criteria in Solid Tumors v1.1).Results:Eighty patients were enrolled and treated;75(93.8%)patients had measurable disease at baseline.Most had metastatic disease and received at least one prior therapy for advanced/metastatic disease(n=79;98.8%).At primary analysis(data cutoff July 8,2021;median follow-up 15.2 months),overall ORR[46.7%;95%confidence interval(95%CI),35.1−58.6;one-sided P<0.0001]and ORR across tumor-specific subgroups[colorectal(n=46):39.1%(95%CI,25.1–54.6);gastric/gastroesophageal junction(n=9):55.6%(95%CI,21.2−86.3);others(n=20):60.0%(95%CI,36.1−80.9)]were significantly greater with tislelizumab vs.a prespecified historical control ORR of 10%;five(6.7%)patients had complete responses.Median DoR,PFS,and overall survival were not reached with long-term follow-up(data cutoff December 5,2022;median follow-up 28.9 months).Tislelizumab was well tolerated with no unexpected safety signals.Treatment-related adverse events(TRAEs)of grade≥3 occurred in 53.8%of patients;7.5%of patients discontinued treatment due to TRAEs.Conclusions:Tislelizumab demonstrated a significant ORR improvement in patients with previously treated,locally advanced unresectable or metastatic MSI-H/dMMR tumors and was generally well tolerated.展开更多
Although transvaginal mesh(TVM)repair is no longer used in some countries,long-term outcomes after TVM surgery are of great importance globally.However,reports with follow-up>10 years are limited.Thus,this study ai...Although transvaginal mesh(TVM)repair is no longer used in some countries,long-term outcomes after TVM surgery are of great importance globally.However,reports with follow-up>10 years are limited.Thus,this study aimed to report outcomes in a prospective cohort with at least 10 years of follow-up.Women with stageⅢ–Ⅳsymptomatic prolapse were approached consecutively from 2008 to 2013 at one tertiary hospital.The main outcome measure was symptomatic failure.Secondary outcomes included anatomic failure,recurrence,patient satisfaction,complications,and reoperation.The Kaplan-Meier curve was used to estimate the cumulative failure rate.Of the 121 patients enrolled in the study,103(85.1%)completed a median follow-up of 11 years.The estimated probability rates of symptomatic and anatomic failure were 17.6%and 8.8%in 11 years,respectively.The estimated incidence of symptomatic failure increased by 8.2%between 5 and 11 years;however,the corresponding rate for anatomic failure was 3.7%.The most common complication was vaginal mesh exposure,and its estimated probability increased from 19.3%to 28.4%from 5 to 11 years,respectively.Office trimming resolved 80.0%of vaginal exposures.These patients did not report decreased overall satisfaction.Patients with vaginal mesh exposure requiring>3 office procedures or mesh removal in the operating room(5.8%by 11 years)had lower satisfaction rates(P<0.01)and were defined as having severe mesh exposure.The rates of postoperative pain,reoperation,and Patient Global Impression of Improvement≥2 were 2.5%,3.3%,and 94.2%,respectively.The results of this study implied that TVM treatment gradually increased the symptomatic failure rate but provided durable anatomical support of the vaginal wall.Vaginal mesh exposure was common in women who were largely not sexually active;however,80%of the cases could be managed in the outpatient clinic,which did not affect patient satisfaction.展开更多
Osteoarthritis(OA),in which M1 macrophage polarization in the synovium exacerbates disease progression,is a major cause of cartilage degeneration and functional disabilities.Therapeutic strategies of OA designed to in...Osteoarthritis(OA),in which M1 macrophage polarization in the synovium exacerbates disease progression,is a major cause of cartilage degeneration and functional disabilities.Therapeutic strategies of OA designed to interfere with the polarization of macrophages have rarely been reported.Here,we report that SHP099,as an allosteric inhibitor of src-homology 2-containing protein tyrosine phosphatase 2(SHP2),attenuated osteoarthritis progression by inhibiting M1 macrophage polarization.We demonstrated that M1 macrophage polarization was accompanied by the overexpression of SHP2 in the synovial tissues of OA patients and OA model mice.Compared to wild-type(WT)mice,myeloid lineage conditional Shp2 knockout(c KO)mice showed decreased M1 macrophage polarization and attenuated severity of synovitis,an elevated expression of cartilage phenotype protein collagen II(COL2),and a decreased expression of cartilage degradation markers collagen X(COL10)and matrix metalloproteinase3(MMP3)in OA cartilage.Further mechanistic analysis showed that SHP099 inhibited lipopolysaccharide(LPS)-induced Toll-like receptor(TLR)signaling mediated by nuclear factor kappa B(NF-κB)and PI3K—AKT signaling.Moreover,intra-articular injection of SHP099 also significantly attenuated OA progression,including joint synovitis and cartilage damage.These results indicated that allosteric inhibition of SHP2 might be a promising therapeutic strategy for the treatment of OA.展开更多
We present mobile vehicle lidar observations in Tianjin, China during the spring, summer, and winter of 2016. Mobile observations were carried out along the city border road of Tianjin to obtain the vertical distribut...We present mobile vehicle lidar observations in Tianjin, China during the spring, summer, and winter of 2016. Mobile observations were carried out along the city border road of Tianjin to obtain the vertical distribution characteristics of PM2.5. Hygroscopic growth was not considered since relative humidity was less than 60% during the observation experiments. PM2.5 profile was obtained with the linear regression equation between the particle extinction coefficient and PM2.5 mass concentration. In spring, the vertical distribution of PM2.5 exhibited a hierarchical structure. In addition to a layer of particles that gathered near the ground, a portion of particles floated at 0.6–2.5-km height. In summer and winter, the fine particles basically gathered below 1 km near the ground. In spring and summer, the concentration of fine particles in the south was higher than that in the north because of the influence of south wind. In winter, the distribution of fine particles was opposite to that measured during spring and summer. High concentrations of PM2.5 were observed in the rural areas of North Tianjin with a maximum of 350 μg m^–3 on 13 December2016. It is shown that industrial and ship emissions in spring and summer and coal combustion in winter were the major sources of fine particles that polluted Tianjin. The results provide insights into the mechanisms of haze formation and the effects of meteorological conditions during haze–fog pollution episodes in the Tianjin area.展开更多
目前全球约有2.57亿慢性乙型肝炎病毒(hepatitis B virus,HBV)感染者,是当前最为突出的公共卫生问题之一.HBV感染的肝细胞内稳定存在的共价闭合环状DNA(cccDNA)是造成HBV感染持续、抗病毒治疗停药后病毒反弹的重要原因.现有Anti-HBV药...目前全球约有2.57亿慢性乙型肝炎病毒(hepatitis B virus,HBV)感染者,是当前最为突出的公共卫生问题之一.HBV感染的肝细胞内稳定存在的共价闭合环状DNA(cccDNA)是造成HBV感染持续、抗病毒治疗停药后病毒反弹的重要原因.现有Anti-HBV药物难以有效清除或直接抑制肝内cccDNA是慢性乙肝难以治愈的关键瓶颈.缺乏简单易行的cccDNA定量检测方法,影响了靶向cccDNA的Anti-HBV新药研发进展,也阻碍了这一指标在慢性乙肝患者临床管理实践中的应用.Southern blot被认为是目前cccDNA实验室检测的"金标准",但其操作复杂且灵敏度低,不适合于高通量药物筛选及临床应用.基于PCR的cccDNA检测方法相对操作简单、检测灵敏度更高,但其可靠性仍有待考验.本文系统整理分析了cccDNA样品提取和测定方法的研究现状与进展,希望通过综合比较不同cccDNA检测技术的性能和特点,为cccDNA相关基础研究、药物发展与临床研究提供方法学参考.展开更多
Osteoporosis is the most common degenerative orthopedic disease in the elderly.Recently,the therapeutic methods for osteoporosis have shifted towards the regulation of local immunity in bone tissues,which could provid...Osteoporosis is the most common degenerative orthopedic disease in the elderly.Recently,the therapeutic methods for osteoporosis have shifted towards the regulation of local immunity in bone tissues,which could provide a suitable environment for the positive regulation of bone metabolism,promoting osteogenic differentiation and inhibiting osteoclast differentiation.Our previous work demonstrated that iron oxide nanoparticles(IONPs)could positively regulate bone metabolism in vitro.In this study,we further demonstrated that daily administration of IONPs relieved estrogen deficiency-induced osteoporosis via scavenging reactive oxygen species in vivo.Meanwhile,IONPs promoted the osteogenic differentiation of bone marrow mesenchymal stem cells and inhibited the osteoclast differentiation of monocytes from IONPs treated mice.Besides,alendronate,a clinically used anti-osteoporosis bisphosphate,was employed to precisely deliver the IONPs to the bone tissues and played a synergically therapeutic role.Eventually,we verified the bone targeting ability,therapeutic efficiency,and biocompatibility of the novel bone target iron oxides in ovariectomy-induced osteoporotic mice.By applying BTNPs,the OVX-induced osteoporosis was significantly revised in mice models via the positive regulation of bone metabolism.展开更多
Objective:To provide a possible basis for the anti-aging effect of modified Qiongyu paste(MQP).Methods:Ultra-high-performance liquid chromatography-Q-Orbitrap mass spectrometry was applied to confirm the effective com...Objective:To provide a possible basis for the anti-aging effect of modified Qiongyu paste(MQP).Methods:Ultra-high-performance liquid chromatography-Q-Orbitrap mass spectrometry was applied to confirm the effective components of MQP that we had identified from databases and research literature.Then,network pharmacology was employed to predict the possible underlying mechanism of MQP against aging.According to the overlap with age-related gene targets,we obtained key targets of MQP against aging using protein-protein interaction analyses.Superoxide dismutase(SOD)tests were performed in vitro and in vivo.Western blotting of P62 and LC3B and quantitative polymerase chain reaction of the expression of the P62,LC3B,HO-1,Keap1,and Nrf2 genes were conducted on H_(2)O_(2) -induced PC12 cells.Enzyme-linked immunosorbent assays of tumor necrosis factor-a and interleukin-6 were conducted on a D-galactose-induced aging mice model.Results:A total of 44 compounds in MQP were finally identified,and 48 gene targets were considered related to anti-aging.Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analyses linked the principal anti-aging mechanisms of MQP to oxidative resistance,genomic stabilization,and growth hormone regulation.In vitro,H_(2)O_(2)-induced PC12 cells showed that MQP was able to activate SOD,prolong telomeres,and enhance the expression levels of P62,LC3B,HO-1,Keap1,and Nrf2.The quantitative polymerase chain reaction results were affirmed with the reactive oxygen species inhibitor N-acetylcysteine and the reactive oxygen species agonist diallyl-tetrasulfide.In vivo,the D-gal-induced aging mice showed that MQP increased SOD in the brain and reduced tumor necrosis factor-α and interleukin-6 in the serum.Thus,our results suggest that the mechanism of the anti-aging effect of MQP primarily involves antagonizing oxidative stress.Conclusion:From the analyses and experimental validation,we may conclude that oxidative stress resistance may be a potential mechanism of the MQP anti-aging effect.展开更多
基金sponsored by BeiGene.Third-party medical writing assistance was provided by Ghina Yaacoub,MSc,of Ashfield MedComms,an Inizio Company,and funded by BeiGene.
文摘Objective:The open-label,phase II RATIONALE-209 study evaluated tislelizumab(anti-programmed cell death protein 1 antibody)as a tissue-agnostic monotherapy for microsatellite instability-high(MSI-H)/mismatch repair-deficient(dMMR)tumors.Methods:Adults with previously treated,locally advanced unresectable or metastatic MSI-H/dMMR solid tumors were enrolled.Patients received tislelizumab 200 mg intravenously every 3 weeks.Objective response rate(ORR;primary endpoint),duration of response(DoR),and progression-free survival(PFS)were assessed by independent review committee(Response Evaluation Criteria in Solid Tumors v1.1).Results:Eighty patients were enrolled and treated;75(93.8%)patients had measurable disease at baseline.Most had metastatic disease and received at least one prior therapy for advanced/metastatic disease(n=79;98.8%).At primary analysis(data cutoff July 8,2021;median follow-up 15.2 months),overall ORR[46.7%;95%confidence interval(95%CI),35.1−58.6;one-sided P<0.0001]and ORR across tumor-specific subgroups[colorectal(n=46):39.1%(95%CI,25.1–54.6);gastric/gastroesophageal junction(n=9):55.6%(95%CI,21.2−86.3);others(n=20):60.0%(95%CI,36.1−80.9)]were significantly greater with tislelizumab vs.a prespecified historical control ORR of 10%;five(6.7%)patients had complete responses.Median DoR,PFS,and overall survival were not reached with long-term follow-up(data cutoff December 5,2022;median follow-up 28.9 months).Tislelizumab was well tolerated with no unexpected safety signals.Treatment-related adverse events(TRAEs)of grade≥3 occurred in 53.8%of patients;7.5%of patients discontinued treatment due to TRAEs.Conclusions:Tislelizumab demonstrated a significant ORR improvement in patients with previously treated,locally advanced unresectable or metastatic MSI-H/dMMR tumors and was generally well tolerated.
基金supported by the National Natural Science Foundation of China(81830043,81771561)the National High Level Hospital Clinical Research Funding(2022-PUMCH-A-113,2022-PUMCH-C-031)+1 种基金the National Key Research and Development Program of China(2018YFC2002201)the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences(2020-PT320-003)。
文摘Although transvaginal mesh(TVM)repair is no longer used in some countries,long-term outcomes after TVM surgery are of great importance globally.However,reports with follow-up>10 years are limited.Thus,this study aimed to report outcomes in a prospective cohort with at least 10 years of follow-up.Women with stageⅢ–Ⅳsymptomatic prolapse were approached consecutively from 2008 to 2013 at one tertiary hospital.The main outcome measure was symptomatic failure.Secondary outcomes included anatomic failure,recurrence,patient satisfaction,complications,and reoperation.The Kaplan-Meier curve was used to estimate the cumulative failure rate.Of the 121 patients enrolled in the study,103(85.1%)completed a median follow-up of 11 years.The estimated probability rates of symptomatic and anatomic failure were 17.6%and 8.8%in 11 years,respectively.The estimated incidence of symptomatic failure increased by 8.2%between 5 and 11 years;however,the corresponding rate for anatomic failure was 3.7%.The most common complication was vaginal mesh exposure,and its estimated probability increased from 19.3%to 28.4%from 5 to 11 years,respectively.Office trimming resolved 80.0%of vaginal exposures.These patients did not report decreased overall satisfaction.Patients with vaginal mesh exposure requiring>3 office procedures or mesh removal in the operating room(5.8%by 11 years)had lower satisfaction rates(P<0.01)and were defined as having severe mesh exposure.The rates of postoperative pain,reoperation,and Patient Global Impression of Improvement≥2 were 2.5%,3.3%,and 94.2%,respectively.The results of this study implied that TVM treatment gradually increased the symptomatic failure rate but provided durable anatomical support of the vaginal wall.Vaginal mesh exposure was common in women who were largely not sexually active;however,80%of the cases could be managed in the outpatient clinic,which did not affect patient satisfaction.
基金supported by the National Science Foundation of China(NSFC 81802196,81572129,81872877,91853109,and 81772335)Key Program of NSFC(81730067,China)+3 种基金Special Program of Chinese Academy of Science(XDA16020805,China)Jiangsu Provincial Key Medical Center Foundation(China)Jiangsu Provincial Medical Outstanding Talent Foundation(China)Jiangsu Provincial Key Medical Talent Foundation(China)。
文摘Osteoarthritis(OA),in which M1 macrophage polarization in the synovium exacerbates disease progression,is a major cause of cartilage degeneration and functional disabilities.Therapeutic strategies of OA designed to interfere with the polarization of macrophages have rarely been reported.Here,we report that SHP099,as an allosteric inhibitor of src-homology 2-containing protein tyrosine phosphatase 2(SHP2),attenuated osteoarthritis progression by inhibiting M1 macrophage polarization.We demonstrated that M1 macrophage polarization was accompanied by the overexpression of SHP2 in the synovial tissues of OA patients and OA model mice.Compared to wild-type(WT)mice,myeloid lineage conditional Shp2 knockout(c KO)mice showed decreased M1 macrophage polarization and attenuated severity of synovitis,an elevated expression of cartilage phenotype protein collagen II(COL2),and a decreased expression of cartilage degradation markers collagen X(COL10)and matrix metalloproteinase3(MMP3)in OA cartilage.Further mechanistic analysis showed that SHP099 inhibited lipopolysaccharide(LPS)-induced Toll-like receptor(TLR)signaling mediated by nuclear factor kappa B(NF-κB)and PI3K—AKT signaling.Moreover,intra-articular injection of SHP099 also significantly attenuated OA progression,including joint synovitis and cartilage damage.These results indicated that allosteric inhibition of SHP2 might be a promising therapeutic strategy for the treatment of OA.
基金Supported by the National Key Project of Ministry of Science and Technology of China(2016YFC0203302)National 863 Program for High Technology Research and Development(2014AA06A512)+2 种基金National(Key)Basic Research and Development(973)Program of China(2014CB447900)National Natural Science Foundation of China(91544232,41305126,and 41605020)Strategic Priority Research Program of the Chinese Academy of Sciences(XDB05040300)
文摘We present mobile vehicle lidar observations in Tianjin, China during the spring, summer, and winter of 2016. Mobile observations were carried out along the city border road of Tianjin to obtain the vertical distribution characteristics of PM2.5. Hygroscopic growth was not considered since relative humidity was less than 60% during the observation experiments. PM2.5 profile was obtained with the linear regression equation between the particle extinction coefficient and PM2.5 mass concentration. In spring, the vertical distribution of PM2.5 exhibited a hierarchical structure. In addition to a layer of particles that gathered near the ground, a portion of particles floated at 0.6–2.5-km height. In summer and winter, the fine particles basically gathered below 1 km near the ground. In spring and summer, the concentration of fine particles in the south was higher than that in the north because of the influence of south wind. In winter, the distribution of fine particles was opposite to that measured during spring and summer. High concentrations of PM2.5 were observed in the rural areas of North Tianjin with a maximum of 350 μg m^–3 on 13 December2016. It is shown that industrial and ship emissions in spring and summer and coal combustion in winter were the major sources of fine particles that polluted Tianjin. The results provide insights into the mechanisms of haze formation and the effects of meteorological conditions during haze–fog pollution episodes in the Tianjin area.
文摘目前全球约有2.57亿慢性乙型肝炎病毒(hepatitis B virus,HBV)感染者,是当前最为突出的公共卫生问题之一.HBV感染的肝细胞内稳定存在的共价闭合环状DNA(cccDNA)是造成HBV感染持续、抗病毒治疗停药后病毒反弹的重要原因.现有Anti-HBV药物难以有效清除或直接抑制肝内cccDNA是慢性乙肝难以治愈的关键瓶颈.缺乏简单易行的cccDNA定量检测方法,影响了靶向cccDNA的Anti-HBV新药研发进展,也阻碍了这一指标在慢性乙肝患者临床管理实践中的应用.Southern blot被认为是目前cccDNA实验室检测的"金标准",但其操作复杂且灵敏度低,不适合于高通量药物筛选及临床应用.基于PCR的cccDNA检测方法相对操作简单、检测灵敏度更高,但其可靠性仍有待考验.本文系统整理分析了cccDNA样品提取和测定方法的研究现状与进展,希望通过综合比较不同cccDNA检测技术的性能和特点,为cccDNA相关基础研究、药物发展与临床研究提供方法学参考.
基金supported by Key Program of NSFC(81730067)Major Project of NSFC(81991514)+10 种基金National Science Foundation of China(Grant No 81802135,82002370)Jiangsu Provincial Key Medical Center FoundationJiangsu Provincial Medical Outstanding Talent FoundationJiangsu Provincial Medical Youth Talent FoundationJiangsu Provincial Key Medical Talent Foundationthe Fundamental Research Funds for the Central Universities(14380493,14380494)China Postdoctoral Science Foundation(Grant No 2019M661806,Grant No 2020M671456)Natural Science Foundation of Jiangsu Province(Grant No BK20200117,BK20200121)Program of Innovation and Entrepreneurship of Jiangsu ProvinceJiangsu postdoctoral research support project(Grant No 2021K059A)Nanjing University Innovation Program for PhD candidates(CXYJ21-62).
文摘Osteoporosis is the most common degenerative orthopedic disease in the elderly.Recently,the therapeutic methods for osteoporosis have shifted towards the regulation of local immunity in bone tissues,which could provide a suitable environment for the positive regulation of bone metabolism,promoting osteogenic differentiation and inhibiting osteoclast differentiation.Our previous work demonstrated that iron oxide nanoparticles(IONPs)could positively regulate bone metabolism in vitro.In this study,we further demonstrated that daily administration of IONPs relieved estrogen deficiency-induced osteoporosis via scavenging reactive oxygen species in vivo.Meanwhile,IONPs promoted the osteogenic differentiation of bone marrow mesenchymal stem cells and inhibited the osteoclast differentiation of monocytes from IONPs treated mice.Besides,alendronate,a clinically used anti-osteoporosis bisphosphate,was employed to precisely deliver the IONPs to the bone tissues and played a synergically therapeutic role.Eventually,we verified the bone targeting ability,therapeutic efficiency,and biocompatibility of the novel bone target iron oxides in ovariectomy-induced osteoporotic mice.By applying BTNPs,the OVX-induced osteoporosis was significantly revised in mice models via the positive regulation of bone metabolism.
基金This study was supported by the National Key Research and Development Program of China(2019YFC1710105).
文摘Objective:To provide a possible basis for the anti-aging effect of modified Qiongyu paste(MQP).Methods:Ultra-high-performance liquid chromatography-Q-Orbitrap mass spectrometry was applied to confirm the effective components of MQP that we had identified from databases and research literature.Then,network pharmacology was employed to predict the possible underlying mechanism of MQP against aging.According to the overlap with age-related gene targets,we obtained key targets of MQP against aging using protein-protein interaction analyses.Superoxide dismutase(SOD)tests were performed in vitro and in vivo.Western blotting of P62 and LC3B and quantitative polymerase chain reaction of the expression of the P62,LC3B,HO-1,Keap1,and Nrf2 genes were conducted on H_(2)O_(2) -induced PC12 cells.Enzyme-linked immunosorbent assays of tumor necrosis factor-a and interleukin-6 were conducted on a D-galactose-induced aging mice model.Results:A total of 44 compounds in MQP were finally identified,and 48 gene targets were considered related to anti-aging.Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analyses linked the principal anti-aging mechanisms of MQP to oxidative resistance,genomic stabilization,and growth hormone regulation.In vitro,H_(2)O_(2)-induced PC12 cells showed that MQP was able to activate SOD,prolong telomeres,and enhance the expression levels of P62,LC3B,HO-1,Keap1,and Nrf2.The quantitative polymerase chain reaction results were affirmed with the reactive oxygen species inhibitor N-acetylcysteine and the reactive oxygen species agonist diallyl-tetrasulfide.In vivo,the D-gal-induced aging mice showed that MQP increased SOD in the brain and reduced tumor necrosis factor-α and interleukin-6 in the serum.Thus,our results suggest that the mechanism of the anti-aging effect of MQP primarily involves antagonizing oxidative stress.Conclusion:From the analyses and experimental validation,we may conclude that oxidative stress resistance may be a potential mechanism of the MQP anti-aging effect.
